Internet Of Things Iot In Healthcare MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy ApplicationBy End UserBy Deployment ModeBy Connectivity Technology

Internet of Things in healthcare refers to the network of connected medical and wellness devices, embedded sensors, and the software platforms that collect, transmit, and analyze the resulting patient and operational data. The category spans implantable and wearable sensors, hospital-grade monitoring equipment, and the network, database, and analytics layers that turn device readings into clinical or administrative decisions, alongside the integration and support services needed to deploy them. Buyers include hospitals and clinics, individual patients managing chronic conditions, health insurers, biotech and pharmaceutical research organizations, and public health authorities.

The global internet of things iot in healthcare market stood at USD 92 billion in 2025. A forecast-period rate of 18.62% takes it to USD 427.38 billion by 2034, and the study reports every year in between, passing USD 35.5 billion in 2020, USD 78.8 billion in 2024, USD 109.02 billion in 2026 and USD 222.33 billion in 2030.

On the component axis, growth rates run from 14.31% for Others Sensor Devices up to 21.4% for Application Development (support and maintenance). Wearable Sensor Devices carries the volume: USD 19.27 billion and 20.94% of revenue in 2025, USD 77.57 billion and 18.15% in 2034. The lines gaining share are Database Layer, Analytics Layer, System Integration, Consulting and Application Development (support and maintenance). Wearable Sensor Devices, Implantable Sensor Devices, Others Sensor Devices and Network Layer lose share without losing revenue.

Cut by application, the largest line is Patient Monitoring: 38% of 2025 revenue, worth USD 34.96 billion, and 42% at USD 179.5 billion by 2034. It is also the fastest-growing line on this axis at 19.94%, so the split concentrates over the period instead of balancing. Both this axis and the component one divide the same revenue, which is why they are alternative views, not components.

USD 34.96 billion of 2025 revenue is generated in North America, 38% of the global total and the largest regional share; it reaches USD 141.04 billion by 2034. Europe is next at 27% and USD 24.84 billion, and Middle East and Africa last at 5%. Because Asia Pacific and Latin America take share, the revenue added by 2034 concentrates instead of spreading across all five regions.

Coverage extends to five regions, nine component lines and five segmentation axes over the full fifteen years. The 2025 total itself is triangulated from published sources and category proxies, with no independently sourced count behind it, and the splits below are estimated on that same basis, a bound on their precision worth carrying into any use of them.

• Revenue grows from USD 92 billion in 2025 to USD 427.38 billion in 2034, a compound annual rate of 18.62%, having reached USD 78.8 billion in 2024 from USD 35.5 billion in 2020.
• Wearable Sensor Devices is the largest component line at USD 19.27 billion in 2025, a 20.94% share, reaching USD 77.57 billion and 18.15% of revenue by 2034.
• Application Development (support and maintenance) is the fastest-growing line at 21.4%, lifting its share from 9.19% in 2025 to 11.34% in 2034 and its revenue from USD 8.46 billion to USD 48.47 billion.
• Against a base case of USD 427.38 billion in 2034, the study also reports a bear case at USD 388.92 billion and a bull case at USD 465.85 billion, with the assumptions behind each set out separately.
• The largest region is North America, generating USD 34.96 billion in 2025 (38% of the global total) and USD 141.04 billion by 2034, ahead of Europe at 27%.
• 84% of North America's base-year revenue comes from the United States alone: USD 29.37 billion in 2025, rising to USD 117.06 billion by 2034, which is why it is that region's worked example.
• Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region, not as a single blended series.

Read across the forecast period, the global internet of things iot in healthcare market shows movement in three places: component composition, regional weight, and the 18.62% rate applied to the whole.

Not one of them points downward. Growth is everywhere in absolute terms, and the interest is entirely in where it lands.

Composition shifts on the component axis. Application Development (support and maintenance) grows at 21.4% across 2026-2034 against 14.31% for Others Sensor Devices, the widest spread on the component axis. By 2034 the two sit at 11.34% and 5.61% of revenue, against 9.19% and 7.79% in 2025. The revenue figures behind that are USD 8.46 billion to USD 48.47 billion and USD 7.17 billion to USD 23.98 billion. Both expand; where a supplier sits on the axis still decides whether it tracks the market.

Regional weight shifts toward Asia Pacific and Latin America. Asia Pacific moves from 24% of revenue in 2025 to 30% in 2034, worth USD 22.08 billion rising to USD 128.21 billion; Latin America moves from 6% of revenue in 2025 to 7.3% in 2034, worth USD 5.52 billion rising to USD 31.2 billion. Against that, North America at 38% moving to 33%, Europe at 27% moving to 25%, Middle East and Africa at 5% moving to 4.7%, a fall in share, not in revenue. Growth is therefore not something a participant inherits from the market; it depends on which regions its revenue is weighted toward.

A continuation, not an inflection. Reading the series: USD 35.5 billion in 2020, USD 78.8 billion in 2024, USD 92 billion in 2025, USD 109.02 billion in 2026, USD 222.33 billion in 2030 and USD 427.38 billion in 2034. Against 20.98% through the historical period, the 18.62% forecast rate is a continuation; no year in the series interrupts it. That moves the planning question away from timing a turn and onto the component and regional mixes, where the actual movement is.

Growth is concentrated in Application Development (support and maintenance)

Separate the 18.62% into its parts and three show up: an already-large base compounding, the component mix moving toward its faster lines, and regional growth landing unevenly.

What holds the forecast back

Where the forecast could be beaten

Concentration on the component axis

In North America, 38% of global revenue puts 2025 at USD 34.96 billion with USD 141.04 billion projected for 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.

Share settles at 33% in 2034, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

Segment composition follows the global pattern: Wearable Sensor Devices largest at 20.94% of 2025 revenue, Application Development (support and maintenance) fastest at 21.4%. Revenue for North America is broken out by every segmentation axis and by country in the full report.

USD 29.37 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 117.06 billion by 2034. 84% of the region in 2025 means the regional figures are, in practice, a view of this market with others attached. The region itself runs USD 34.96 billion to USD 141.04 billion over the same period, and this is the market carrying the country-level detail in the full report.

The component pattern in the United States is the global one: 20.94% of 2025 revenue in Wearable Sensor Devices, 18.15% by 2034, against 21.4% growth in Application Development (support and maintenance) taking it from 9.19% to 11.34%. Its 84% weight in North America means those movements carry straight into the regional totals. The full report reports the United States by component separately.

In the United States, connected medical devices fall under the Food and Drug Administration's device framework, with classification determining whether a product needs premarket notification or full premarket approval before it reaches a hospital or home setting. Software components that analyze patient data are reviewed under the agency's software-as-a-medical-device guidance, and any device that stores or transmits patient information must also satisfy HIPAA's privacy and security requirements. Wireless connectivity is subject to separate equipment certification, and labelling must state intended use, network requirements, and any coexistence considerations for hospital wireless environments.

In the United States the field is Medtronic, Cisco Systems, Inc., IBM Corporation, GE Healthcare, Microsoft Corporation, SAP SE, Infosys Limited, Cerner Corporation and Diabetizer Ltd. & Co. KG. Two different problems sit on the same axis: holding Wearable Sensor Devices at 20.94% of 2025 revenue, and taking Application Development (support and maintenance) while it grows at 21.4%. Per-company positioning and share at country level are in the full report only.

Canada is sized at USD 5.59 billion in 2025, rising to USD 23.98 billion by 2034; 6.08% of global revenue and 16% of North America. It is reported separately from the United States across every segmentation axis in the full report.

USD 24.84 billion of 2025 revenue is generated in Europe, 27% of the global internet of things iot in healthcare market on the way to USD 106.85 billion by 2034. That makes it the second-largest region covered, in 2025 and again in 2034.

Its share moves to 25% by 2034, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Within the region the component split tracks the global one; 20.94% of 2025 revenue in Wearable Sensor Devices, fastest growth of 21.4% in Application Development (support and maintenance). The full report breaks Europe out along every axis and by country.

Germany is the largest market within Europe, generating USD 7.45 billion in 2025 and projected to reach USD 32.06 billion by 2034. At 30% of the region in 2025 it leads, but a majority of Europe's revenue is generated in other markets. Set against USD 24.84 billion and USD 106.85 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

Germany buys along the same lines as the market globally; Wearable Sensor Devices first at 20.94% of 2025 revenue and 18.15% in 2034, Application Development (support and maintenance) fastest at 21.4% on a share moving from 9.19% to 11.34%. With 30% of Europe concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Per-component revenue for Germany appears on its own in the full report.

In Germany, connected health-monitoring devices are regulated as medical devices under the EU Medical Device Regulation, which requires a risk-based classification and, for most connected products, an assessment by a notified body before the CE mark can be applied. The Federal Institute for Drugs and Medical Devices acts as the competent national authority and oversees market surveillance once a product is placed on sale. Manufacturers must also conform to recognized standards covering electrical safety and software lifecycle management for connected systems, and any personal health data collected must be handled in line with the General Data Protection Regulation. Labelling must be in German and state the intended purpose clearly.

Medtronic, Cisco Systems, Inc., IBM Corporation, GE Healthcare, Microsoft Corporation, SAP SE, Infosys Limited, Cerner Corporation and Diabetizer Ltd. & Co. KG are the suppliers covered in Germany. Volume sits in Wearable Sensor Devices at 20.94% of 2025 revenue; movement sits in Application Development (support and maintenance) at 21.4% growth. A supplier weighted toward Europe is competing over a base of USD 24.84 billion in 2025 reaching USD 106.85 billion by 2034, 27% of global revenue at the start of that period.

Within Europe, the United Kingdom accounts for 26% of regional revenue and 7.02% of the global total, worth USD 6.46 billion in 2025 and USD 27.78 billion by 2034.

Within Europe, France accounts for 20% of regional revenue and 5.4% of the global total, worth USD 4.97 billion in 2025 and USD 21.37 billion by 2034.

In Asia Pacific, 24% of global revenue puts 2025 at USD 22.08 billion and reaches USD 128.21 billion by 2034. That makes it the third-largest region covered, in 2025 and again in 2034.

Share climbs to 30% by 2034, at a pace above the 18.62% global rate, so this region warrants separate treatment and should not be scaled off the total.

Segment composition follows the global pattern: Wearable Sensor Devices largest at 20.94% of 2025 revenue, Application Development (support and maintenance) fastest at 21.4%. Revenue for Asia Pacific is broken out by every segmentation axis and by country in the full report.

The largest single market in Asia Pacific is China, at USD 9.27 billion in 2025 and USD 51.28 billion in 2034. Its 42% of base-year regional revenue leads the region, though enough sits elsewhere that Asia Pacific is not a proxy for it. Against regional totals of USD 22.08 billion in 2025 and USD 128.21 billion in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Wearable Sensor Devices at 20.94% of 2025 revenue, easing to 18.15% by 2034, and the fastest is Application Development (support and maintenance) at 21.4%, from 9.19% to 11.34%. Its 42% weight in Asia Pacific means those movements carry straight into the regional totals. The full report reports China by component separately.

In China, connected healthcare devices are regulated by the National Medical Products Administration, which classifies medical devices by risk and requires registration before a product can be marketed, with higher-risk connected devices needing clinical evaluation as part of that registration. Because these devices collect and transmit personal health data, suppliers must also comply with the Personal Information Protection Law and the Data Security Law, both of which impose requirements on cross-border data transfer and local storage of health information. Labelling and instructions must be provided in Chinese, and any claims about diagnostic or monitoring function must match the scope approved on the registration certificate.

Medtronic, Cisco Systems, Inc., IBM Corporation, GE Healthcare, Microsoft Corporation, SAP SE, Infosys Limited, Cerner Corporation and Diabetizer Ltd. & Co. KG are the suppliers covered in China. Wearable Sensor Devices, at 20.94% of 2025 revenue, is where the volume sits, and Application Development (support and maintenance), growing at 21.4%, is where position changes hands over the forecast period. A supplier weighted toward Asia Pacific is competing over a base of USD 22.08 billion in 2025 reaching USD 128.21 billion by 2034, 24% of global revenue at the start of that period.

4.8% of global revenue is generated in Japan; USD 4.42 billion in 2025, reaching USD 23.08 billion in 2034, and 20% of Asia Pacific.

Within Asia Pacific, India accounts for 15% of regional revenue and 3.6% of the global total, worth USD 3.31 billion in 2025 and USD 23.08 billion by 2034.

Latin America holds 6% of the global internet of things iot in healthcare market in 2025, worth USD 5.52 billion with USD 31.2 billion projected for 2034. That makes it the fourth-largest region covered, in 2025 and again in 2034.

7.3% of global revenue sits here by 2034, up from the 2025 level, at a pace above the 18.62% global rate, so this region warrants separate treatment and should not be scaled off the total.

Segment composition follows the global pattern: Wearable Sensor Devices largest at 20.94% of 2025 revenue, Application Development (support and maintenance) fastest at 21.4%. Latin America is reported axis by axis and country by country in the full study.

The largest single market in Latin America is Brazil, at USD 3.04 billion in 2025 and USD 17.16 billion in 2034. 55% of the region in the base year makes it the largest market here without making it the region. Set against USD 5.52 billion and USD 31.2 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

The component pattern in Brazil is the global one: 20.94% of 2025 revenue in Wearable Sensor Devices, 18.15% by 2034, against 21.4% growth in Application Development (support and maintenance) taking it from 9.19% to 11.34%. Because the country carries 55% of Latin America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-component revenue for Brazil appears on its own in the full report.

In Brazil, medical-grade connected health devices fall under the oversight of ANVISA, the national health surveillance agency, which classifies devices by risk and requires registration before import or sale, generally through a local technical representative who takes responsibility for regulatory compliance. Devices must conform to applicable Brazilian technical standards for electrical and software safety, and any data collected through remote monitoring is subject to the General Data Protection Law, which governs how patient information may be stored, processed, and shared. Labelling and user instructions must be presented in Portuguese, and marketing claims must stay within the scope granted at registration.

In Brazil the field is Medtronic, Cisco Systems, Inc., IBM Corporation, GE Healthcare, Microsoft Corporation, SAP SE, Infosys Limited, Cerner Corporation and Diabetizer Ltd. & Co. KG. Wearable Sensor Devices, at 20.94% of 2025 revenue, is where the volume sits, and Application Development (support and maintenance), growing at 21.4%, is where position changes hands over the forecast period. That makes Latin America a 6% share of 2025 global revenue, USD 5.52 billion rising to USD 31.2 billion, for any supplier deciding where to concentrate.

1.8% of global revenue is generated in Mexico; USD 1.66 billion in 2025, reaching USD 9.36 billion in 2034, and 30% of Latin America.

5% of the global internet of things iot in healthcare market sits in Middle East and Africa in 2025, worth USD 4.6 billion rising to USD 20.09 billion in 2034. By revenue it sits fifth across the study, and the ranking does not change between 2025 and 2034.

4.7% of global revenue sits here in 2034, below the 2025 level, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.

Wearable Sensor Devices leads here as it does globally, at 20.94% of 2025 revenue, and Application Development (support and maintenance) again grows fastest at 21.4%. Per-axis and per-country detail for Middle East and Africa sits in the full report.

Saudi Arabia is the largest market within Middle East and Africa, generating USD 1.61 billion in 2025 and projected to reach USD 7.03 billion by 2034. 35% of the region in the base year makes it the largest market here without making it the region. The region itself runs USD 4.6 billion to USD 20.09 billion over the same period, and this is the market carrying the country-level detail in the full report.

Demand in Saudi Arabia follows the component mix reported at global level: Wearable Sensor Devices is the largest line at 20.94% of 2025 revenue, moving to 18.15% by 2034, while Application Development (support and maintenance) grows fastest at 21.4% and takes its share from 9.19% to 11.34%. Its 35% weight in Middle East and Africa means those movements carry straight into the regional totals. Saudi Arabia carries its own component breakdown in the full report.

In Saudi Arabia, connected health devices are regulated by the Saudi Food and Drug Authority, which requires a medical device marketing authorization before any such product can be sold, alongside registration of the local authorized representative responsible for the device once it enters the market. Classification follows a risk-based system similar to other Gulf and international frameworks, and manufacturers must demonstrate conformity to recognized safety and quality standards for connected medical equipment. Because these devices transmit data over wireless networks, equipment must also be approved by the Communications and Information Technology Commission. Labelling must be provided in Arabic alongside the original language and state the approved intended use.

Medtronic, Cisco Systems, Inc., IBM Corporation, GE Healthcare, Microsoft Corporation, SAP SE, Infosys Limited, Cerner Corporation and Diabetizer Ltd. & Co. KG are the suppliers covered in Saudi Arabia. Volume sits in Wearable Sensor Devices at 20.94% of 2025 revenue; movement sits in Application Development (support and maintenance) at 21.4% growth. Weighting toward Middle East and Africa means competing for 5% of 2025 global revenue, a base of USD 4.6 billion moving to USD 20.09 billion across the forecast period.

1.25% of global revenue is generated in the United Arab Emirates; USD 1.15 billion in 2025, reaching USD 5.02 billion in 2034, and 25% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by component, application, end user, deployment mode, connectivity technology, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.